LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | AZD 5438 | 1.11 | uM | LJP6 | 1 | J03 | 72 | hr | 1694 | 1765 | 11220 | 0.1573 | 0.0151 |
MCF 10A | AZD 5438 | 1.11 | uM | LJP6 | 2 | J03 | 72 | hr | 1694 | 1652 | 11309 | 0.1461 | -0.0092 |
MCF 10A | AZD 5438 | 1.11 | uM | LJP6 | 3 | J03 | 72 | hr | 1694 | 1615 | 11121 | 0.1452 | -0.0175 |
MCF 10A | AZD 5438 | 3.33 | uM | LJP6 | 1 | J02 | 72 | hr | 1694 | 643 | 11220 | 0.0573 | -0.2990 |
MCF 10A | AZD 5438 | 3.33 | uM | LJP6 | 2 | J02 | 72 | hr | 1694 | 479 | 11309 | 0.0424 | -0.3695 |
MCF 10A | AZD 5438 | 3.33 | uM | LJP6 | 3 | J02 | 72 | hr | 1694 | 418 | 11121 | 0.0376 | -0.4028 |
MCF 10A | AZD 5438 | 10 | uM | LJP6 | 1 | J01 | 72 | hr | 1694 | 573 | 11220 | 0.0511 | -0.3280 |
MCF 10A | AZD 5438 | 10 | uM | LJP6 | 2 | J01 | 72 | hr | 1694 | 565 | 11309 | 0.0500 | -0.3303 |
MCF 10A | AZD 5438 | 10 | uM | LJP6 | 3 | J01 | 72 | hr | 1694 | 585 | 11121 | 0.0526 | -0.3241 |
MCF 10A | Pelitinib | 0.04 | uM | LJP5 | 1 | I18 | 72 | hr | 1694 | 8812 | 11042 | 0.7980 | 0.8399 |
MCF 10A | Pelitinib | 0.04 | uM | LJP5 | 2 | I18 | 72 | hr | 1694 | 8586 | 11099 | 0.7736 | 0.8193 |
MCF 10A | Pelitinib | 0.04 | uM | LJP5 | 3 | I18 | 72 | hr | 1694 | 8700 | 11168 | 0.7790 | 0.8246 |
MCF 10A | Pelitinib | 0.12 | uM | LJP5 | 1 | I17 | 72 | hr | 1694 | 5862 | 11042 | 0.5309 | 0.5825 |
MCF 10A | Pelitinib | 0.12 | uM | LJP5 | 2 | I17 | 72 | hr | 1694 | 5652 | 11099 | 0.5092 | 0.5594 |
MCF 10A | Pelitinib | 0.12 | uM | LJP5 | 3 | I17 | 72 | hr | 1694 | 5908 | 11168 | 0.5290 | 0.5827 |
MCF 10A | Pelitinib | 0.37 | uM | LJP5 | 1 | I16 | 72 | hr | 1694 | 2555 | 11042 | 0.2314 | 0.1641 |
MCF 10A | Pelitinib | 0.37 | uM | LJP5 | 2 | I16 | 72 | hr | 1694 | 2409 | 11099 | 0.2170 | 0.1386 |
MCF 10A | Pelitinib | 0.37 | uM | LJP5 | 3 | I16 | 72 | hr | 1694 | 2683 | 11168 | 0.2402 | 0.1841 |
MCF 10A | Pelitinib | 1.11 | uM | LJP5 | 1 | I15 | 72 | hr | 1694 | 2755 | 11042 | 0.2495 | 0.1970 |
MCF 10A | Pelitinib | 1.11 | uM | LJP5 | 2 | I15 | 72 | hr | 1694 | 2492 | 11099 | 0.2245 | 0.1529 |
MCF 10A | Pelitinib | 1.11 | uM | LJP5 | 3 | I15 | 72 | hr | 1694 | 2599 | 11168 | 0.2327 | 0.1703 |
MCF 10A | Pelitinib | 3.33 | uM | LJP5 | 1 | I14 | 72 | hr | 1694 | 2413 | 11042 | 0.2185 | 0.1397 |
MCF 10A | Pelitinib | 3.33 | uM | LJP5 | 2 | I14 | 72 | hr | 1694 | 2356 | 11099 | 0.2123 | 0.1293 |
MCF 10A | Pelitinib | 3.33 | uM | LJP5 | 3 | I14 | 72 | hr | 1694 | 2591 | 11168 | 0.2320 | 0.1690 |
MCF 10A | Pelitinib | 10 | uM | LJP5 | 1 | I13 | 72 | hr | 1694 | 1636 | 11042 | 0.1482 | -0.0129 |